DK147918C - Analogifremgangsmaade til fremstilling af thymosin alfa1 (18 - 28) eller farmaceutisk acceptable salte deraf - Google Patents
Analogifremgangsmaade til fremstilling af thymosin alfa1 (18 - 28) eller farmaceutisk acceptable salte derafInfo
- Publication number
- DK147918C DK147918C DK169478A DK169478A DK147918C DK 147918 C DK147918 C DK 147918C DK 169478 A DK169478 A DK 169478A DK 169478 A DK169478 A DK 169478A DK 147918 C DK147918 C DK 147918C
- Authority
- DK
- Denmark
- Prior art keywords
- alfa1
- thymosine
- analogue
- preparation
- acceptable salts
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06086—Dipeptides with the first amino acid being basic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/57581—Thymosin; Related peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
- C07K5/06043—Leu-amino acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US78989877A | 1977-04-22 | 1977-04-22 | |
| US78989877 | 1977-04-22 | ||
| US87156378 | 1978-01-23 | ||
| US05/871,563 US4116951A (en) | 1977-04-22 | 1978-01-23 | [Asn2 ]-thymosin α1 and analogs thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DK169478A DK169478A (da) | 1978-10-23 |
| DK147918B DK147918B (da) | 1985-01-07 |
| DK147918C true DK147918C (da) | 1985-08-19 |
Family
ID=27120967
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK169478A DK147918C (da) | 1977-04-22 | 1978-04-18 | Analogifremgangsmaade til fremstilling af thymosin alfa1 (18 - 28) eller farmaceutisk acceptable salte deraf |
Country Status (18)
| Country | Link |
|---|---|
| JP (1) | JPS53137914A (da) |
| AT (1) | AT364470B (da) |
| CA (1) | CA1113088A (da) |
| CH (3) | CH641152A5 (da) |
| DE (1) | DE2817082A1 (da) |
| DK (1) | DK147918C (da) |
| ES (1) | ES469016A1 (da) |
| FI (1) | FI781241A (da) |
| FR (2) | FR2401134A1 (da) |
| GB (1) | GB1590668A (da) |
| GR (1) | GR71886B (da) |
| HU (1) | HU180783B (da) |
| IT (1) | IT1113134B (da) |
| LU (1) | LU79488A1 (da) |
| NL (1) | NL7804364A (da) |
| NO (2) | NO781404L (da) |
| PT (1) | PT67937B (da) |
| SE (1) | SE447262B (da) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4116951A (en) * | 1977-04-22 | 1978-09-26 | Hoffmann-La Roche Inc. | [Asn2 ]-thymosin α1 and analogs thereof |
| DE2919592A1 (de) * | 1979-05-15 | 1981-01-15 | Max Planck Gesellschaft | Verfahren zur herstellung von thymosin- alpha 1 und derivaten davon |
| EP0033384B1 (de) * | 1980-01-18 | 1984-02-15 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Thymosin-alpha-1-Fragmente enthaltende Arzneimittel mit immunstimulierender Wirkung, und Thymosin-alpha-1-Fragmente |
| US4339427A (en) * | 1980-04-14 | 1982-07-13 | Hoffmann-La Roche Inc. | Radioimmunoassay of thymosinα |
| EP0056594B1 (de) * | 1981-01-14 | 1984-09-12 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Thymosin-alpha-1-Fragmente enthaltende Arzneimittel mit immunregulierender Wirkung und Thymosin-alpha-1-Fragmente |
| CN1058500C (zh) * | 1993-02-03 | 2000-11-15 | 施塞克龙药品公司 | 胸腺素α－1衍生物 |
| US6262230B1 (en) * | 1994-01-28 | 2001-07-17 | Sciclone Pharmaceuticals Inc. | Analogs of thymosin α1 |
-
1978
- 1978-04-17 CH CH408878A patent/CH641152A5/de not_active IP Right Cessation
- 1978-04-18 DK DK169478A patent/DK147918C/da not_active IP Right Cessation
- 1978-04-19 DE DE19782817082 patent/DE2817082A1/de not_active Ceased
- 1978-04-20 FR FR7811686A patent/FR2401134A1/fr active Granted
- 1978-04-20 GR GR56036A patent/GR71886B/el unknown
- 1978-04-21 CA CA301,643A patent/CA1113088A/en not_active Expired
- 1978-04-21 IT IT22629/78A patent/IT1113134B/it active
- 1978-04-21 AT AT0286178A patent/AT364470B/de not_active IP Right Cessation
- 1978-04-21 PT PT67937A patent/PT67937B/pt unknown
- 1978-04-21 NO NO781404A patent/NO781404L/no unknown
- 1978-04-21 HU HU78HO2067A patent/HU180783B/hu unknown
- 1978-04-21 SE SE7804612A patent/SE447262B/sv not_active IP Right Cessation
- 1978-04-21 LU LU79488A patent/LU79488A1/de unknown
- 1978-04-21 FI FI781241A patent/FI781241A/fi not_active Application Discontinuation
- 1978-04-21 ES ES469016A patent/ES469016A1/es not_active Expired
- 1978-04-21 JP JP4673978A patent/JPS53137914A/ja active Pending
- 1978-04-21 GB GB1574/78A patent/GB1590668A/en not_active Expired
- 1978-04-24 NL NL7804364A patent/NL7804364A/xx not_active Application Discontinuation
- 1978-12-15 FR FR7835404A patent/FR2405926A1/fr active Granted
-
1982
- 1982-05-13 NO NO821608A patent/NO148924C/no unknown
- 1982-11-05 CH CH645082A patent/CH641153A5/de not_active IP Right Cessation
- 1982-11-05 CH CH644982A patent/CH640218A5/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| FR2401134B1 (da) | 1983-09-30 |
| DK147918B (da) | 1985-01-07 |
| GB1590668A (en) | 1981-06-03 |
| LU79488A1 (de) | 1979-05-25 |
| DE2817082A1 (de) | 1978-11-02 |
| IT7822629A0 (it) | 1978-04-21 |
| CH641153A5 (en) | 1984-02-15 |
| ATA286178A (de) | 1981-03-15 |
| FI781241A (fi) | 1978-10-23 |
| NO821608L (no) | 1978-10-24 |
| NO148924B (no) | 1983-10-03 |
| HU180783B (en) | 1983-04-29 |
| NO781404L (no) | 1978-10-24 |
| NL7804364A (nl) | 1978-10-24 |
| CA1113088A (en) | 1981-11-24 |
| SE7804612L (sv) | 1978-12-20 |
| IT1113134B (it) | 1986-01-20 |
| JPS53137914A (en) | 1978-12-01 |
| FR2405926A1 (fr) | 1979-05-11 |
| SE447262B (sv) | 1986-11-03 |
| FR2405926B1 (da) | 1983-09-09 |
| PT67937A (en) | 1978-05-01 |
| FR2401134A1 (fr) | 1979-03-23 |
| GR71886B (da) | 1983-08-04 |
| AT364470B (de) | 1981-10-27 |
| CH640218A5 (en) | 1983-12-30 |
| NO148924C (no) | 1984-01-11 |
| PT67937B (en) | 1980-04-07 |
| DK169478A (da) | 1978-10-23 |
| ES469016A1 (es) | 1980-01-01 |
| CH641152A5 (en) | 1984-02-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK149449C (da) | Analogifremgangsmaade til fremstilling af carbostyrilderivater eller farmaceutisk acceptable salte deraf | |
| DK152753C (da) | Analogifremgangsmaade til fremstilling af 2-hydroxymethyl-3,4,5-trihydroxypiperidinderivater eller farmaceutisk acceptable salte eller stereoisomere deraf | |
| DK145339C (da) | Analogifremgangsmaade til fremstilling af 4-amino-5-hexensyre eller farmaceutisk acceptable salte deraf | |
| DK152495C (da) | Analogifremgangsmaade til fremstilling af n2-arylsulfonyl-l-argininamider eller farmaceutisk tolerable salte deraf | |
| DK163244C (da) | Analogifremgangsmaade til fremstilling af 7-oe2-(2-aminothiazol-4-yl)-2-oxyimino-acetamidoaa-ceph-3-em-4-carboxylsyrederivater eller fysiologisk acceptable salte deraf | |
| DK152114C (da) | Analogifremgangsmaade til fremstilling af propenylaminer eller farmaceutisk acceptable salte deraf | |
| DK161968C (da) | Analogifremgangsmaade til fremstilling af imidazo-pyrazolo-pyrimidiner eller farmaceutisk acceptable salte deraf | |
| DK146160C (da) | Analogifremgangsmaade til fremstilling af n-(5-tetrazolyl)-4-oxo-4h-pyrimido(2,1-b)benzothiazol-3-carboxamider eller farmaceutisk acceptable salte deraf med baser | |
| DK158658C (da) | Analogifremgangsmaade til fremstilling af 9-aminoalkylfluorener eller farmaceutisk acceptable salte deraf | |
| DK155670C (da) | Analogifremgangsmaade til fremstilling af sesquiterpenderivater eller farmaceutisk acceptable salte deraf | |
| DK161699C (da) | Analogifremgangsmaade til fremstilling af 4-aryl-4-piperidincarbinoler eller farmaceutisk acceptable salte deraf | |
| DK150196C (da) | Analogifremgangsmaade til fremstilling af 0-(3-amino-2-hydroxypropyl)-amidoximderivater eller farmaceutisk acceptable salte deraf | |
| DK145263C (da) | Analogifremgangsmaade til fremstilling af imidazothiaziner eller farmaceutisk acceptable salte deraf | |
| DK151805C (da) | Analogifremgangsmaade til fremstilling af 20,21-di-nor-eburnameninderivater eller farmaceutisk acceptable additionssalte deraf | |
| DK149611C (da) | Analogifremgangsmaade til fremstilling af trh-analoge tripeptidamider eller terapeutisk acceptable komplexer eller salte deraf | |
| DK152208C (da) | Analogifremgangsmaade til fremstilling af 2-phenylamino-phenyleddikesyreamider eller farmaceutisk acceptable salte deraf | |
| DK147918C (da) | Analogifremgangsmaade til fremstilling af thymosin alfa1 (18 - 28) eller farmaceutisk acceptable salte deraf | |
| DK144033C (da) | Analogifremgangsmaade til fremstilling af l-3-(3,4-dihydroxy-phenyl)-2-methyl-alanin-peptider eller farmakologisk acceptable salte deraf | |
| DK162102C (da) | Analogifremgangsmaade til fremstilling af 3-o-(beta-d-glucoronopyranosyl)-sojasapogenol b eller farmaceutisk acceptable salte deraf | |
| DK149093C (da) | Analogifremgangsmaade til fremstilling af pentapeptidderivater eller farmaceutisk acceptable salte deraf | |
| DK148019C (da) | Analogifremgangsmaade til fremstilling af 2-pyridylaminobenzoesyrer eller farmaceutisk acceptable salte deraf | |
| DK232677A (da) | Fremgangsmade til fremstilling af dihydro eller tetrahydroiminothiaziner eller farmaceutisk acceptable salte deraf | |
| DK150521C (da) | Analogifremgangsmaade til fremstilling af n2-arylsulfonyl-l-argininamider eller farmaceutisk acceptable salte deraf | |
| DK164169C (da) | Analogifremgangsmaade til fremstilling af 7-alfa-methoxycephalosporiner eller farmaceutisk acceptable salte deraf samt et mellemprodukt til anvendelse herved | |
| DK232877A (da) | Fremgangsmade til fremstilling af 2-imino-3-aminothiazolidiner eller farmaceutisk acceptable salte deraf |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PBP | Patent lapsed | ||
| B1 | Patent granted (law 1993) | ||
| PBP | Patent lapsed |